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Abstract: The lymphocyte platelet ratio (LPR) is an inflammatory marker that 
can be used to identify the severity of coronary heart disease (CHD). This 
study aims to determine the correlation between the lymphocyte platelet ratio 
and Gensini scores in CHD patients. This research used correlative analytical 
research with a cross-sectional design. The sample was selected by consecutive 
sampling technique and obtained 51 respondents. The calculation of the LPR 
was carried out by dividing the number of platelets and lymphocytes in the 
volume unit of 103/mm3. Meanwhile, the Gensini score assessment was carried 
out by multiplying the percentage of blockages and location of blockages based 
on the result of coronary angiography. Based on the Gensini score, the sample 
in this study was classified as mild atherosclerosis with the Gensini score <25 
points, and severe atherosclerosis with the Gensini score ≥25 points. The data 
were analyzed using the Pearson correlation test. The result showed that 
the average LPR value in samples with severe atherosclerosis was 124.6  and  
115.3 in mild atherosclerosis. Based on the result of statistical analysis using the 
Pearson test, the p-value was 0.107. It can be concluded that there is no 
significant correlation between the lymphocyte platelet ratio and Gensini scores 
in CHD patients. 
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Abstrak: Rasio platelet limfosit (LPR) adalah penanda inflamasi yang dapat digunakan 
untuk mengidentifikasi tingkat keparahan penyakit jantung koroner (PJK). Penelitian ini 
bertujuan untuk mengetahui korelasi antara rasio platelet limfosit dan skor Gensini 
pada pasien PJK. Penelitian ini menggunakan penelitian analitik korelatif dengan 
desain cross-sectional. Sampel dipilih dengan teknik consecutive sampling dan diperoleh 
51 responden. Perhitungan LPR dilakukan dengan membagi jumlah trombosit dan 
limfosit dalam satuan volume 103/mm3. Sementara itu, penilaian skor Gensini 
dilakukan dengan mengalikan persentase penyumbatan dan lokasi penyumbatan 
berdasarkan hasil angiografi koroner. Berdasarkan skor Gensini, sampel dalam 
penelitian ini diklasifikasikan sebagai aterosklerosis ringan dengan skor Gensini <25 
poin, dan aterosklerosis berat dengan skor Gensini ≥25 poin. Data dianalisis 
menggunakan uji korelasi Pearson. Hasil penelitian menunjukkan bahwa nilai LPR 
rata-rata dalam sampel dengan aterosklerosis berat adalah 124,6 dan 115,3 pada 
aterosklerosis ringan. Berdasarkan hasil analisis statistik menggunakan uji Pearson, 
didapatkan p-value 0,107. Dapat disimpulkan bahwa tidak ada korelasi yang signifikan 
antara rasio platelet limfosit dan skor Gensini pada pasien PJK. 
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Coronary heart disease (CHD) is a 
cardiovascular disease with high morbidity and 
mortality all over the world. World Health 
Organization (WHO) estimates in 2008, out of 17.3 
million people who died of cardiovascular disease, 
7.3 million of them were estimated to die 
of coronary heart disease, and 6.2 million died of a 
stroke.1 Meanwhile, the estimated prevalence 
of CHD in Indonesia in 2013 was 0.5% or around 
883,447 people based on the medical diagnosis and 
1.5% or around 2,650,340 people based on 
symptoms.2 
The general pathological process that causes 
CHD is atherosclerosis. Atherosclerosis is a chronic 
inflammatory response in the artery wall initiated 
by damage to the endothelium.3 This chronic 
inflammatory response to the atherosclerosis 
process is associated with platelet and lymphocyte 
production. An increase in platelet can trigger the 
development of atherosclerosis and plaque 
destabilization. Platelets will secrete chemokines, 
cytokines, and other inflammatory mediators such 
as interleukin-1 (IL-1), IL-3, and IL-6 associated with 
inflammation of blood vessels. Besides, 
lymphocytopenia is also found in chronic 
inflammation due to an increase in lymphocyte 
apoptosis which is independently associated with 
an increase in morbidity and mortality in CHD.4 
This lymphocyte platelet ratio (LPR) is a 
prognostic sign that combines two parameters that 
predict risk into one. In the previous studies, it was 
found that LPR is a common risk factor and 
biomarker commonly used in predicting severe 
atherosclerosis and is positively correlated with 
Gensini scores.5 A study conducted by Akboga et al. 
revealed that LPR is significantly and independently 
associated with the severity of coronary 
atherosclerosis in patients with stable CHD.6 Also, 
LPR is a predictor of cardiovascular mortality in 
patients with ST-segment Elevation Myocardial 
Infarction (STEMI) with an increase in mortality in 
the group with higher LPR.7 
The researchers are interested in identifying 
the correlation between the lymphocytes platelet 
ratio and Gensini scores in CHD patients in Mataram 
City Hospital since the lymphocytes platelet ratio is 
a blood calculation routinely performed without 
additional costs and is an available marker that can 
help identify the severity of CHD. Based on the 
result of this study, it can be taken into 
consideration to use an easy and inexpensive LPR 
examination as an independent predictor of 
severity in CHD patients. 
 
MATERIALS AND METHOD 
 
This research is a correlative analytic study 
that aims to determine the correlation between the 
lymphocytes platelet ratio and Gensini scores in 
patients with CHD in Mataram City Hospital using a 
cross-sectional design conducted from May to 
December 2017. The subjects were patients who 
had been diagnosed with CHD based on clinical 
symptoms, physical examination, and additional 
examinations, such as an electrocardiogram (ECG), 
echocardiography, treadmill, and coronary 
angiography in Mataram City Hospital. Samples 
were selected using non-probability sampling 
techniques, namely consecutive sampling, and the 
number of samples used in this study was 51 
respondents. 
Inclusion criteria were patients who have 
been diagnosed with CHD based on ECG, 
echocardiography, treadmill, and coronary 
angiography, and patients who approved and 
signed a statement of willingness as a research 
sample. Meanwhile, the exclusion criteria included: 
(1) undergoing acute coronary syndrome (ACS), (2) 
undergoing an infectious disease, (3) currently 
taking anti-inflammatory medication, and (4) having 
a history of malignant disease. The selection was 
conducted by interviewing patients and identifying 
their medical records. 
Data collection and instruments used were 
guided interviews using a questionnaire, a complete 
recording of blood test results identified from the 
patients’ medical records, and a recording of the 
result of coronary angiography identified from the 
patients’ medical records. Calculation of the ratio of 
lymphocyte platelets was carried out by dividing the 
number of platelets and lymphocytes in the volume 
unit of 103/mm3, and the Gensini score assessment 
was carried out by multiplying the percentage of 
blockage and location of blockage based on the 
result of coronary angiography. Based on the 
Gensini score, the sample in this study was classified 
as mild atherosclerosis with the Gensini score <25 
points and severe atherosclerosis with the Gensini 
score ≥25 points. The data analysis technique used 
was the Pearson correlation test (parametric test), 
while the normal data distribution and the 
alternative test used were the Spearman 
correlation test (non-parametric test). 
This study has been granted approval from 
the Ethics Committee of the Faculty of Medicine at 
the University of Mataram under number 172 / 









Table 1. Characteristics of Research Subjects 
Patient Characteristics n % 
Age     
≤57 years old 28 54.9  
> 57 years old 23 45.1  
Gender     
Male 36 70.6  
Female 15 29.4  
BMI     
Underweight 2 3.9 
Normal 29 56.9 
Overweight 6 11.8 
Obesity 14 27.5 
Total of Platelet     
Below normal 2 3.9 
Normal 48 94.1 
Above normal 1 2 
Total of Lymphocyte     
Below normal 0 0 
Normal 49 96.1 
Above normal 2 3.9 
Total of Leukocyte     
Below normal 0 0 
Normal 45 88.2 
Above normal 6 11.8 
Lymphocyte Platelet Ratio     
<101 18 35.3 
101-171 24 47.1 
> 171 9 17.6 
Diagnosis     
Non-significant CHD 11 21.6 
CHD 1 VD 7 13.7 
CHD 2 VD 15 29.4 
CHD 3 VD 18 35.3 
Gensini score     
Mild atherosclerosis 25 49 
Severe atherosclerosis 26 51 
Diabetes Mellitus     
Yes 19 37.3 
No 32 62.7 
Hypertension     
Yes 29 56.9 
No 22 43.1 
Smoking History     
Non-smoker 30 58.8 
Smoker 21 41.2 
  
The number of subjects who met the 
inclusion criteria was 51 people. The characteristics 
of the subjects consisted of age, gender, body mass 
index (BMI), interpretation of lymphocyte platelet 
ratio (LPR), diagnosis of CHD, interpretation of 
Gensini scores, comorbid diseases (diabetes 
mellitus and hypertension) and smoking history. 
Based on Table 1, it showed that the total 
number of the study sample, which was ≤57 years 
old, was 28 respondents (54.9%), and >57 years old 
was 23 respondents (45.1%). Gender distribution in 
this study was higher in males than females, with a 
total of 36 males (70.6%) and 15 females 
(29.4%). Based on the BMI sample, it can be seen 
that there are two underweight respondents (3.9%), 
29 respondents (56.9%) with normal BMI, six 
overweight respondents (11.8%), and 14 obese 
respondents (27.5%). Furthermore, based on the 
result of a complete blood examination, it revealed 
that samples who had a total platelet below normal 
category were two respondents (3.9%), those who 
had normal platelet were 48 respondents (94.1%), 
and those who had a total platelet above normal 
category were one respondent (2%). In terms of 
lymphocytes examination, it was found that 49 
respondents (96.1%) had normal lymphocytes, and 
two respondents (3.9%) had lymphocytes above the 
normal category. Based on the number of 
leukocytes, it revealed that 45 respondents (88.2%) 
had the number of leukocytes within the normal 
category, and six respondents (11.8%) had the 
number of leukocytes above the normal category. 
Moreover, the calculation of the lymphocyte 
platelet ratio found that 18 people (35.3%) had LPR 
<101, 24 people (47.1%) had LPR 101-171, and 9 people 
(17.6%) had LPR >171.  
Based on the diagnosis of the study sample, 
11 people (21.6%) were diagnosed with non-
significant CHD, seven respondents (13.7%) were 
diagnosed with CHD 1 VD, 15 respondents (29.4%) 
were diagnosed with CAD 2 VD, and 18 respondents 
(35.3%) were diagnosed with CAD 3 VD. The Gensini 
score showed that samples with mild 
atherosclerosis were 25 respondents (49%) while 26 
respondents (51%) had severe 
atherosclerosis. Based on the sample of comorbid 
disease, 19 respondents (37.3%) had diabetes 
mellitus, and 32 respondents (62.7%) did 
not. Furthermore, it was found that 29 respondents 
(56.9%) had hypertension, and 22 people (43.1%) did 
not. The samples in this study mostly did not 
smoke, with a total of 30 non-smokers (58.8%) and 
21 smokers (41.2%). 
 
 
Figure 1. Average LPR in mild and severe atherosclerosis 
 
 
Gambar 1. Rerata RTL pada Aterosklerosis Ringan dan Berat 
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Based on Figure 1, it was found that the 
average LPR value in samples with mild 
atherosclerosis (Gensini score of <25 points) was 
115.3. Meanwhile, the average LPR value in samples 
with severe atherosclerosis (Gensini score of ≥25 
points) was 124.6. It indicated that the mean of LPR 
in samples with severe atherosclerosis is higher 
than the average value of samples with mild 
atherosclerosis. Furthermore, based on the Pearson 
test result, it revealed the value of p = 0.107 (p> 
0.05), indicating that there was no significant 
correlation between the lymphocyte platelet ratio 





Based on the result of the study, it was found 
that most of the study subjects were males who 
were ≤57 years old. The average BMI of the subjects 
was classified as normal with the higher diagnosis 
of CHD 3 VD, which was mostly accompanied by 
hypertension and no smoking history. The 
calculation of the lymphocyte platelet ratio showed 
that 18 respondents (35.3%) had LPR <101, 24 
respondents (47.1%) had LPR 101-171, and 9 
respondents (17.6%) had LPR >171. Furthermore, 
based on the Gensini score, it was found that 
samples with mild atherosclerosis were 25 
respondents (49%), and 26 respondents (51%) had 
severe atherosclerosis. 
Assessment of the severity of CHD by using 
Gensini scores is widely used in previous 
studies. The Gensini score is a rating system for 
the severity of coronary heart stenosis. It is carried 
out by multiplying the constriction percentage 
score and the location of the lesion in the coronary 
arteries.5 In this study, it was found that the 
diagnosis variable was significantly correlated with 
the severity of CHD assessed by the Gensini score 
with the result of the value p=0.001. It indicates that 
samples with a diagnosis of CAD 3 VD have a higher 
severity compared to the ones with a diagnosis of 
non-significant CAD, CAD 1 VD, and CAD 2 VD. 
One simple marker that can be used in 
identifying the severity of CHD is the lymphocyte 
platelet ratio (LPR) obtained from complete blood 
tests routinely performed at a low cost.8  An 
increase in platelet activation plays a vital role in the 
initiation and the development of atherosclerosis. 
The total platelet is associated with both short and 
long-term mortality in patients with STEMI, NSTEMI, 
and unstable angina pectoris.7 Furthermore, 
lymphocyte deficiency can also increase the 
development of atherosclerosis. Lymphocytopenia 
is detected in inflammation and is associated with 
cardiovascular incidents.4 
In a meta-analysis study conducted by Li et 
al. regarding the prognostic value of lymphocyte 
platelet ratio in acute coronary syndromes (ACS), it 
showed that a high LPR value is an independent 
factor associated with all mortality causes and 
cardiovascular incidents in patients with ACS.8 
Furthermore, in the previous studies, it revealed 
that LPR is significantly and independently 
associated with the severity of coronary 
atherosclerosis in patients with stable CHD.6 
In another research conducted by Sari et 
al. (2015),9 it was found that CHD patients had a 
significantly higher lymphocyte neutrophil ratio and 
lymphocyte platelet ratio compared to patients 
with normal coronary angiography results. This LPR 
is a simple method that can predict the severity of 
CHD and can be part of a cardiovascular evaluation 
before coronary angiography.9 LPR is a predictor of 
cardiovascular mortality in patients with ST-
segment Elevation Myocardial Infarction (STEMI) 
with an increase in mortality in the group with 
higher LPR.7 Besides that, LPR is associated with the 
severity of CHD. It has a positive correlation 
indicating that the higher the LPR value is, the 
higher the severity of CHD will be.4 
In this study, it was found that there was no 
significant correlation between the ratio of 
lymphocyte platelets and the Gensini score in 
patients with CHD in Mataram City Hospital with a 
value of p> 0.05.  In contrast, the previous studies 
showed a significant relationship between the ratio 
of lymphocyte platelets and the severity of CHD 
patients assessed by the Gensini score. The contrast 
can be caused by the absence of a control group in 
this study. Aging causes an increase in the 
prevalence of ACS and the deterioration of the 
prognosis. Moreover, it was also found that 
patients who had high LPR were dominated by the 
elderly.7 In contrast, the samples of this study were 
mostly <70 years old that can influence the result of 
the study. 
This study revealed that a total platelet and 
lymphocyte identified in the samples were 
categorized as normal. It affected the result of this 
study shows that only nine respondents had LPR 
value >171 and that the result of this study was 
insignificant. Meanwhile, the previous studies 
assert that an increase in the number of platelets 
could trigger an increase in the number of coronary 
stenoses, which certainly affects the severity of 
CHD. Moreover, a decrease in lymphocytes is also 
independently associated with an increase in 




Another factor that can influence the result 
of this study is the history of the treatment of the 
study samples. Most of the samples in this study 
had received standard CHD therapy, namely statins, 
aspirin, and clopidogrel. Aspirin, an antiplatelet 
agent, frequently given along with clopidogrel, is a 
medicine used to inhibit an ADP receptor. Statin, 
which is an inhibitor to hydroxymethyl glutaric-
coenzyme, is also frequently given.10 These drugs 
can influence the result of this study, such as 
clopidogrel, which has a platelet inhibitory effect 
that can affect the value of the lymphocyte platelet 
ratio. The effects of these drugs are influenced by 
the dose given and the severity of endothelial 
dysfunction and platelet reactivation.11 
LPR values are also influenced by comorbid 
diseases experienced by the study samples, such as 
hypertension and diabetes mellitus. LPR as a marker 
of inflammation significantly increased in the non-
dipper hypertension group, which consisted of 
individuals with a normal systolic and diastolic 
blood.12 In addition, it was also found that LPR 
significantly decreased in prediabetes and early 
stages of diabetes. However, it will be likely to 
increase in the later stages of the disease.13 This 
study did not consider the severity when the study 
sample underwent the comorbid disease. This 
factor is also what has influenced the result of this 
study. 
Thus, several factors that led to the study 
showing insignificant correlation between the 
lymphocyte platelet ratio and Gensini scores in CHD 
patients in Mataram City Hospital are such as there 
was no control group, the majority of the sample 
was <70 years old, and the majority of the total 
platelet and lymphocyte in this study sample is 
categorized as normal. Furthermore, there are 
several confounding factors, such as the history of 
the treatment and comorbidities experienced by 
the samples. 
In terms of the limitations, this study used 
a cross-sectional method and was only conducted 
to CHD patients in City Hospital  (single center-
based study) so that the sample used can only 
describe the CHD population in the city of Mataram. 
It only focused on the influence of one 
inflammatory marker that affects the severity of 
CHD, without considering other inflammatory 
markers such as C-reactive protein and so on. 
Moreover, this study has not been able to establish 
a diagnosis of severity history, which is an exclusion 
criterion in this study by using a standard gold 
examination. In addition, this study cannot control 
the confounding factors that can influence the 
result of this study. 
CONCLUSION 
  
 There is no significant correlation between 
the ratio of lymphocyte platelets and Gensini scores 
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